Charles Cherington - Dec 2, 2022 Form 4 Insider Report for Eterna Therapeutics Inc. (ERNA)

Signature
/s/ Sandra Gurrola, Power of Attorney for Charles Cherington
Stock symbol
ERNA
Transactions as of
Dec 2, 2022
Transactions value $
$923,999
Form type
4
Date filed
12/6/2022, 08:02 PM
Previous filing
Oct 24, 2022
Next filing
Jan 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ERNA Common Stock Purchase $859K +262K +88.82% $3.28 556K Dec 2, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ERNA Warrants (right to buy) Purchase $65.4K +524K $0.13* 524K Dec 2, 2022 Common Stock, par value $0.005 per share 524K $3.28 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person entered into a Securities Purchase Agreement with the Issuer on November 23, 2022, pursuant to which, on December 2, 2022, the reporting person acquired an aggregate of 261,756 units for a purchase price of $3.53 per unit, each unit consisting of one share of common stock, par value $0.05 per share ("Common Stock"), and two warrants, each exercisable to purchase one share of Common Stock at an exercise price of $3.28 per share. The purchase price for each unit included $0.125 for each warrant in accordance with Nasdaq rules.